Case 2: Faricimab in treatment naïve neovascular nAMD patient

Video

Drs Khanani and Khoramnia review the case of a newly diagnosed nAMD patient who showed a rapid response in disease control after starting faricimab therapy.

Sponsored by Roche

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

© 2025 MJH Life Sciences

All rights reserved.